当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1.
Leukemia ( IF 11.4 ) Pub Date : 2020-01-14 , DOI: 10.1038/s41375-020-0707-2
H Pfeifer 1 , G Cazzaniga 2 , V H J van der Velden 3 , J M Cayuela 4 , B Schäfer 5 , O Spinelli 6 , S Akiki 7 , S Avigad 8 , I Bendit 9 , K Borg 10 , H Cavé 11 , L Elia 12 , S C Reshmi 13 , G Gerrard 14 , S Hayette 15 , M Hermanson 16 , A Juh 17 , T Jurcek 18 , M C Chillón 19 , C Homburg 20 , G Martinelli 21 , V Kairisto 22 , T Lange 23 , T Lion 24 , M C Mueller 25 , F Pane 26 , L Rai 27 , C Damm-Welk 28 , T Sacha 29 , S Schnittger 30 , T Touloumenidou 31 , H Valerhaugen 32 , P Vandenberghe 33 , J Zuna 34 , H Serve 1 , E Herrmann 35 , S Markovic 1 , J J M van Dongen 3, 36 , O G Ottmann 37
Affiliation  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

中文翻译:

更正:通过实时定量逆转录酶PCR实时检测e1a2 BCR-ABL1在费城阳性急性淋巴细胞性白血病(Ph + ALL)中的最小残留疾病评估的标准化和共识性指南。

该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-01-14
down
wechat
bug